Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Breast Cancer Res Treat. 2017 Dec;166(3):875-879. doi: 10.1007/s10549-017-4461-8. Epub 2017 Aug 21.
Transgender patients undergoing transitions often receive cross-sex hormonal therapies, placing them at uncertain risk for developing breast cancer. There is limited population-based information about the extent to which transgender patients undergo mammography screening. Our purpose was to determine the extent to which transgender patients undergo mammography screening using nationally representative survey data.
Transgender participants between ages 40-74 in the 2014 Behavioral Risk Factor Surveillance System survey were included. Proportions undergoing mammography screening in the last year or two years were calculated stratified by age category and transition status [male to female(MtF), female to male(FtM), non-conforming]. For each transition status, predictors of mammography screening were calculated using logistic regression.
220 transgender patients were within 40-74 years old(35% were MtF, 51% were FtM, 14% were non-conforming). 60.0% underwent mammography screening within the last year (MtF-54.5%, FtM-64.3%, non-conforming-58.1%). 74.1% underwent screening within the last two years(MtF-70.1%, FtM-75.9%, non-conforming-77.4%). For all transgender patients, income category (OR 1.16, 0.82-1.64), higher education category (OR 1.09, 0.31-3.86) and health insurance (OR 0.38, 0.10-1.41) were not associated with increased adherence to mammography screening. Transgender patients were comparably likely to undergo mammography screening compared with non-transgender patients (Adjusted OR 0.97, 0.58-1.62).
High proportions of transgender survey respondents undergo mammography screening (57.9-66.1% within the last year, 71.9-74.4% within the last two years) in our sample, proportions comparable to non-transgender survey respondents.
进行性别转变的跨性别患者经常接受跨性别激素治疗，因此面临不确定的乳腺癌发病风险。关于跨性别患者接受乳房 X 光筛查的程度，基于人群的信息有限。我们的目的是使用全国代表性调查数据确定跨性别患者接受乳房 X 光筛查的程度。
纳入年龄在 40-74 岁之间的 2014 年行为风险因素监测系统调查中的跨性别参与者。按年龄类别和转变状态[男变女（MtF）、女变男（FtM）、非顺应性]计算过去一年或两年内接受乳房 X 光筛查的比例。对于每种转变状态，使用逻辑回归计算乳房 X 光筛查的预测因素。
220 名跨性别患者年龄在 40-74 岁之间（35%为 MtF，51%为 FtM，14%为非顺应性）。60.0%的人在过去一年接受了乳房 X 光筛查（MtF-54.5%，FtM-64.3%，非顺应性-58.1%）。74.1%的人在过去两年内接受了筛查（MtF-70.1%，FtM-75.9%，非顺应性-77.4%）。对于所有跨性别患者，收入类别（OR 1.16，0.82-1.64）、更高的教育类别（OR 1.09，0.31-3.86）和医疗保险（OR 0.38，0.10-1.41）与增加乳房 X 光筛查的依从性无关。与非跨性别患者相比，跨性别患者接受乳房 X 光筛查的可能性相当（调整后的 OR 0.97，0.58-1.62）。
在我们的样本中，高比例的跨性别调查受访者（过去一年为 57.9-66.1%，过去两年为 71.9-74.4%）接受了乳房 X 光筛查，与非跨性别调查受访者的比例相当。
